High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer-Reference-Cited by-同舟云学术

High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer

Published:1988-09 Issue:9 Volume:24 Page:1499-1503
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

de Gramont Aimery,Krulik Marcel,Cady Jean,Lagadec Bertrand,Maisani Jean-Eric,Loiseau Jean-Philippe,Grange Jean-Didier,Gonzalez-Canali Gustavo,Demuynck Bénédicte,Louvet Christophe,Seroka Jacques,Dray Claude,Debray Jacques

Publisher

Elsevier BV

Subject

Oncology

Reference17 articles.

1. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study;Machover;Cancer Treat Rep,1982

2. Phase I–II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer;Madajewicz;Cancer Res,1984

3. Comparison of continuously-infused 5-FU with bolus injection in treatment of patients with colorectal adenocarcinoma;Seifert;Cancer,1975

4. Leucovorin plus 5-FU: an effective treatment for metastatic colon cancer;Laufman;J Clin Oncol,1987

5. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma;Petrelli;J Clin Oncol,1987

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Real-Life Impact of mFOLFIRI-Based Chemotherapies on Elderly Patients—Should We Let It or Leave It?;Cancers;2023-10-26

2. Modified bi‐weekly cetuximab‐cisplatin and 5‐FU /leucovorin based regimen for effective treatment of recurrent/metastatic head and neck squamous cell carcinoma to reduce chemotherapy exposure of patients;Cancer Reports;2021-06-28

3. 5-FU Induced Atrial Fibrillation in the Context of Ischemic Heart Disease;Clinical Cases in Cardiology;2021

4. Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy;Swiss Medical Weekly;2020-11-24

5. Development and clinical application of bispecific antibody in the treatment of colorectal cancer;Expert Review of Clinical Immunology;2020-07-02